Search research articles
Contact Us
Filters
Showing results (721-730 of 748) with videos related to
Page
of 75
Sort By:
Cancer Discovery
|
March 17, 2021
Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>-Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALL
Matthew A Nix, Kamal Mandal, Huimin Geng, et al.
Hepatology (Baltimore, Md.)
|
November 7, 2023
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations
Zachary M Sellers, David N Assis, Shruti M Paranjape, et al.
The Journal of Trauma and Acute Care Surgery
|
April 23, 2021
Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities
Osaid Alser, Ava Mokhtari, Leon Naar, et al.
Blood
|
February 26, 2015
Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia
Saradhi Mallampati, Xiaohong Leng, Haiqing Ma, et al.
Trials
|
November 16, 2021
Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics
Christopher N Sciamanna, Noel H Ballentine, Melissa Bopp, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 26, 2025
Impact of elexacaftor/tezacaftor/ivacaftor on biomarkers of cystic fibrosis hepatobiliary involvement in the PUSH study
Wen Ye, John C Magee, Suiyuan Huang, et al.
Expert Review of Anti-Infective Therapy
|
November 14, 2020
Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review
Betsy Ann Joseph, Mahmoud Dibas, Kirk W Evanson, et al.
The Lancet. Infectious Diseases
|
May 9, 2016
The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants
Nicholas C Grassly, Ira Praharaj, Sudhir Babji, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 9, 2023
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease
Marilyn J Siegel, Daniel H Leung, Jean P Molleston, et al.
Frontiers in Microbiology
|
December 13, 2021
The Evolution of Regulatory Elements in the Emerging Promoter-Variant Strains of HIV-1 Subtype C
Disha Bhange, Nityanand Prasad, Swati Singh, et al.
Page
of 75
Search research articles
Search
Showing results (721-730 of 748) with videos related to
Sort By:
Page
of 75
Cancer Discovery
|
March 17, 2021
Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>-Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALL
Matthew A Nix, Kamal Mandal, Huimin Geng, et al.
Hepatology (Baltimore, Md.)
|
November 7, 2023
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations
Zachary M Sellers, David N Assis, Shruti M Paranjape, et al.
The Journal of Trauma and Acute Care Surgery
|
April 23, 2021
Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities
Osaid Alser, Ava Mokhtari, Leon Naar, et al.
Blood
|
February 26, 2015
Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia
Saradhi Mallampati, Xiaohong Leng, Haiqing Ma, et al.
Trials
|
November 16, 2021
Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics
Christopher N Sciamanna, Noel H Ballentine, Melissa Bopp, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 26, 2025
Impact of elexacaftor/tezacaftor/ivacaftor on biomarkers of cystic fibrosis hepatobiliary involvement in the PUSH study
Wen Ye, John C Magee, Suiyuan Huang, et al.
Expert Review of Anti-Infective Therapy
|
November 14, 2020
Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review
Betsy Ann Joseph, Mahmoud Dibas, Kirk W Evanson, et al.
The Lancet. Infectious Diseases
|
May 9, 2016
The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants
Nicholas C Grassly, Ira Praharaj, Sudhir Babji, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 9, 2023
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease
Marilyn J Siegel, Daniel H Leung, Jean P Molleston, et al.
Frontiers in Microbiology
|
December 13, 2021
The Evolution of Regulatory Elements in the Emerging Promoter-Variant Strains of HIV-1 Subtype C
Disha Bhange, Nityanand Prasad, Swati Singh, et al.
Page
of 75